Handelsbanken Fonder’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Sell |
40,600
-5,100
| -11% | -$184K | 0.01% | 784 |
|
|
2025
Q1 | $1.8M | Hold |
45,700
| – | – | 0.01% | 692 |
|
|
2024
Q4 | $1.38M | Sell |
45,700
-4,200
| -8% | -$126K | 0.01% | 826 |
|
|
2024
Q3 | $1.17M | Buy |
49,900
+9,200
| +23% | +$215K | ﹤0.01% | 883 |
|
|
2024
Q2 | $724K | Buy |
40,700
+7,500
| +23% | +$133K | ﹤0.01% | 991 |
|
|
2024
Q1 | $505K | Hold |
33,200
| – | – | ﹤0.01% | 1156 |
|
|
2023
Q4 | $567K | Buy |
33,200
+10,900
| +49% | +$186K | ﹤0.01% | 1095 |
|
|
2023
Q3 | $186K | Hold |
22,300
| – | – | ﹤0.01% | 1478 |
|
|
2023
Q2 | $554K | Buy |
22,300
+10,000
| +81% | +$248K | ﹤0.01% | 1014 |
|
|
2023
Q1 | $185K | Buy |
+12,300
| New | +$185K | ﹤0.01% | 1468 |
|
|
2022
Q4 | – | Sell |
-17,200
| Closed | -$102K | – | 1608 |
|
|
2022
Q3 | $102K | Hold |
17,200
| – | – | ﹤0.01% | 1522 |
|
|
2022
Q2 | $73K | Sell |
17,200
-5,000
| -23% | -$21.2K | ﹤0.01% | 1599 |
|
|
2022
Q1 | $211K | Hold |
22,200
| – | – | ﹤0.01% | 1622 |
|
|
2021
Q4 | $422K | Hold |
22,200
| – | – | ﹤0.01% | 1465 |
|
|
2021
Q3 | $739K | Hold |
22,200
| – | – | ﹤0.01% | 1083 |
|
|
2021
Q2 | $861K | Buy |
22,200
+1,100
| +5% | +$42.7K | ﹤0.01% | 1009 |
|
|
2021
Q1 | $1.02M | Hold |
21,100
| – | – | 0.01% | 835 |
|
|
2020
Q4 | $1.1M | Hold |
21,100
| – | – | 0.01% | 782 |
|
|
2020
Q3 | $565K | Hold |
21,100
| – | – | ﹤0.01% | 940 |
|
|
2020
Q2 | $411K | Buy |
+21,100
| New | +$411K | ﹤0.01% | 1056 |
|